PMV Pharmaceuticals Inc

NASDAQ:PMVP  
34.89
+0.41 (+1.19%)
Earnings Announcements

Pmv Pharmaceuticals Reports QTRLY Loss Per Share $1.46

Published: 11/13/2020 13:07 GMT
(PMVP) - Pmv Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights.
Pmv Pharmaceuticals Inc - Qtrly Loss per Share $1.46.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.61

More details on our Analysts Page.